Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). (Q39991768)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). |
scientific article |
Statements
1 reference
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). (English)
1 reference
Swiss Group for Clinical Cancer Research (SAKK)
1 reference
D Koeberle
1 reference
J-F Dufour
1 reference
G Demeter
1 reference
Q Li
1 reference
K Ribi
1 reference
P Samaras
1 reference
P Saletti
1 reference
A D Roth
1 reference
D Horber
1 reference
M Buehlmann
1 reference
A D Wagner
1 reference
M Montemurro
1 reference
G Lakatos
1 reference
J Feilchenfeldt
1 reference
M Peck-Radosavljevic
1 reference
D Rauch
1 reference
B Tschanz
1 reference
G Bodoky
1 reference
15 February 2016
1 reference
1 reference
27
1 reference
5
1 reference
856-861
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference